Aspire Biopharma Holdings, Inc. - ASBP
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 15
Latest filed: Apr 20, 2026
| Form | Count |
|---|---|
| 8-K | 13 |
| 8-K/A | 1 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Apr 20, 2026 | 8-K | Apr 20, 2026 | 0001493152-26-018018 | View |
| Apr 17, 2026 | 8-K/A | Apr 15, 2026 | 0001493152-26-017145 | View |
| Apr 16, 2026 | 8-K | Apr 10, 2026 | 0001493152-26-017054 | View |
| Apr 16, 2026 | 8-K | Apr 15, 2026 | 0001493152-26-017115 | View |
| Apr 16, 2026 | 8-K | Apr 16, 2026 | 0001493152-26-016979 | View |
| Apr 15, 2026 | 8-K | Apr 15, 2026 | 0001493152-26-016683 | View |
| Feb 12, 2026 | SCHEDULE 13G | — | 0001213900-26-015382 | View |
| Feb 12, 2026 | 8-K | Feb 06, 2026 | 0001493152-26-006343 | View |
| Feb 06, 2026 | 8-K | Feb 02, 2026 | 0001493152-26-005640 | View |
| Jan 30, 2026 | 8-K | Jan 26, 2026 | 0001493152-26-004543 | View |
| Jan 15, 2026 | 8-K | Jan 08, 2026 | 0001493152-26-002326 | View |
| Jan 13, 2026 | 8-K | Jan 07, 2026 | 0001493152-26-002057 | View |
| Jan 06, 2026 | 8-K | Jan 01, 2026 | 0001493152-26-000518 | View |
| Nov 14, 2025 | 8-K | Nov 11, 2025 | 0001493152-25-022580 | View |
| Nov 05, 2025 | 8-K | Nov 04, 2025 | 0001493152-25-020891 | View |